Propranolol Therapy

Propranolol Therapy is a pharmacological treatment involving the administration of the non-selective beta-adrenergic receptor blocker propranolol, distinguished within vascular anomalies management by its efficacy in inducing regression of infantile hemangiomas through vasoconstriction, apoptosis, and inhibition of angiogenesis.

4.1K

Publications

191.6K

Citations

14.1K

Authors

2.7K

Institutions

Publications per year

2017–2026

362

Variants

Propranolol Treatment

Authors

14.1K

  1. JC
    Juan Carlos García‐Pagán

    Universitat de Barcelona, Spain

    24 publications · 2.3K citations

    21

    h-index

  2. DG
    David G. Shand

    Vanderbilt University, United States

    23 publications · 2.5K citations

    21

    h-index

  3. TW
    Thomas Walle

    Medical University of South Carolina, United States

    22 publications · 1.1K citations

    18

    h-index

  4. IJ
    Ilona J. Frieden

    University of California, San Francisco, United States

    17 publications · 2K citations

    16

    h-index

  5. DL
    Didier Lebrec

    Hôpital Beaujon, France

    18 publications · 2.1K citations

    16

    h-index

1–5 of 14.1K

Venues

  1. Circulation

    127 publications · 12.6K citations

    69

    h-index

  2. The American Journal of Cardiology

    118 publications · 7.1K citations

    49

    h-index

  3. PubMed

    Repository · 310 publications · 9.1K citations

    46

    h-index

  4. Hepatology

    57 publications · 5.7K citations

    41

    h-index

  5. Clinical Pharmacology & Therapeutics

    CPT · 108 publications · 4.8K citations

    38

    h-index

1–5